Literature DB >> 7937424

The role of autografting in lymphoma.

D W Milligan1, S G Long.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7937424      PMCID： PMC2397661          DOI： 10.1136/pgmj.70.825.475

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  32 in total

1.  Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation.

Authors:  J G Gribben; D C Linch; C R Singer; A K McMillan; M Jarrett; A H Goldstone
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

Review 2.  Bone marrow transplantation in the treatment of patients with lymphoma.

Authors:  J O Armitage
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

3.  Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.

Authors:  J G Gribben; A H Goldstone; D C Linch; G Taghipour; A K McMillan; R L Souhami; H Earl; J D Richards
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

4.  The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.

Authors:  P Colombat; N C Gorin; M P Lemonnier; C Binet; J P Laporte; L Douay; I Desbois; M Lopez; J P Lamagnere; A Najman
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

5.  EBMT experience of autologous bone marrow transplantation in lymphoma.

Authors:  A H Goldstone; J G Gribben
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1989

6.  Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

Authors:  H C Schouten; P J Bierman; W P Vaughan; A Kessinger; J M Vose; D D Weisenburger; J O Armitage
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

7.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

Authors:  T Philip; J O Armitage; G Spitzer; F Chauvin; S Jagannath; J Y Cahn; P Colombat; A H Goldstone; N C Gorin; M Flesh
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

8.  Curative potential of combined modality therapy for advanced Hodgkin's disease.

Authors:  L R Farber; L R Prosnitz; E C Cadman; R Lutes; J R Bertino; D B Fischer
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

9.  Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

Authors:  G L Phillips; S N Wolff; R H Herzig; H M Lazarus; J W Fay; H S Lin; D C Shina; G P Glasgow; R C Griffith; C W Lamb
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

10.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.

Authors:  V T DeVita; R M Simon; S M Hubbard; R C Young; C W Berard; J H Moxley; E Frei; P P Carbone; G P Canellos
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.